M*Modal Reaches Partnership Agreement with Merge Healthcare
Published on January 26, 2012
Continues Expansion of Healthcare IT Partner Ecosystem
Franklin, TN, January 26, 2012 – MModal Inc. (NASDAQ/GS: MODL), a leading provider of clinical narrative capture services, Speech Understanding technology and clinical documentation workflow, today announced that it has entered into a strategic partnership agreement with Merge Healthcare(NASDAQ: MRGE) to integrate its speech and language understanding technology across Merge’s portfolio including its imaging and radiology offerings.
Through this partnership, M*Modal becomes a preferred partner of Merge with plans to integrate its speech and natural language understanding (NLU) into Merge’s solutions to help clients achieve Meaningful Use and contextual narrative capture. Together, M*Modal and Merge will look to accelerate adoption of these innovative speech-based solutions across the Merge network of clients, including 1,500 hospitals and 6,000 clinics with such specialties as imaging (representing 1/3 of all U.S. imaging centers), cardiology, orthopaedics and eye care, along with a full suite of clinical trials solutions.
“We are pleased to welcome Merge Healthcare to the growing family of M*Modal partners,” noted Vern Davenport, Chairman and CEO of M*Modal. “We will provide their clients with our patented speech-enabled solutions that will increase access to key clinical data originating from the provider’s spoken word, meeting them at their current state of readiness. It’s that simple spoken word that enables caregivers to fully capture the patient story, extract clinically relevant data and ultimately enhance the physician’s user experience.”
“Given the increasing marketplace demand for speech-based solutions, we are delighted to add M*Modal to our growing list of partners as it both extends our market reach and enhances our product usability and functionality,” said Jeff Surges, CEO of Merge Healthcare. “We value the innovative nature of M*Modal’s solutions and the company’s commitment to collaboration as it enables healthcare technology leaders like Merge to deliver innovation to its solution offerings that will ultimately enhance our customers’ ability to deliver care.”
M*Modal is a leading provider of clinical narrative capture services, Speech Understanding technology and clinical documentation workflow. M*Modal’s enterprise solutions – including mobile voice capture devices, speech recognition, Natural Language Understanding, Web-based workflow platforms and global network of medical editors – help healthcare facilities facilitate adoption of electronic health records (EHRs), improve patient care, increase physician satisfaction and lower operational costs. For more information, please visit www.mmodal.clientcreative.com.
About Merge Healthcare
Merge Healthcare is a leading provider of enterprise imaging and interoperability solutions, with a client base consisting of more than 1,500 hospitals and 6,000 clinics across the country. Merge solutions facilitate the sharing of images to create a more effective and efficient electronic healthcare experience for patients and physicians. Merge provides enterprise imaging solutions for radiology, cardiology, orthopaedics and eye care; a suite of products for clinical trials; software for financial and pre-surgical management, and applications that fuel the largest modality vendors in the world. Merge’s products have been used by healthcare providers, vendors and researchers worldwide to improve patient care for more than 20 years. Additional information can be found at http://www.merge.com/.
“Safe Harbor” Statement under the U.S. Private Securities Litigation Reform Act of 1995: Statements in this press release regarding M*Modal’s business that are not historical facts are “forward-looking statements” that involve risks and uncertainties. Actual outcomes and results may differ materially from what is expressed or forecasted in forward-looking statements. As a result, forward-looking statements speak only as of the date they were made, and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.